Home Physical Sciences 4. SFC applications for active pharmaceutical ingredient analysis
Chapter
Licensed
Unlicensed Requires Authentication

4. SFC applications for active pharmaceutical ingredient analysis

  • Lu Zeng and Paddi Ekhlassi
Become an author with De Gruyter Brill
Supercritical Fluid Chromatography
This chapter is in the book Supercritical Fluid Chromatography

Abstract

This chapter focuses on utilizing supercritical fluid chromatography (SFC) and its applications in drug development for the analysis of active pharmaceutical ingredient (API) in the manufacturing process. Various screening approaches such as sequential, parallel or tandem column chromatography offers a unique and useful tool for separations of impurities and optimizing the overall selectivity. With the new age of technology, modern SFC instruments can be qualified and chiral and achiral SFC methods can be validated for the GMP API release and/or cleaning testing under the regulatory guidelines. Thus, given the advantageous proprieties of CO2-based mobile phase and low consumption of solvents, we believe that this technology has become an equally valuable primary option for method development and validation in pharmaceutical industry analytical laboratories.

Abstract

This chapter focuses on utilizing supercritical fluid chromatography (SFC) and its applications in drug development for the analysis of active pharmaceutical ingredient (API) in the manufacturing process. Various screening approaches such as sequential, parallel or tandem column chromatography offers a unique and useful tool for separations of impurities and optimizing the overall selectivity. With the new age of technology, modern SFC instruments can be qualified and chiral and achiral SFC methods can be validated for the GMP API release and/or cleaning testing under the regulatory guidelines. Thus, given the advantageous proprieties of CO2-based mobile phase and low consumption of solvents, we believe that this technology has become an equally valuable primary option for method development and validation in pharmaceutical industry analytical laboratories.

Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/9783110618983-004/html
Scroll to top button